167 related articles for article (PubMed ID: 6928240)
1. Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.
Sanfilippo F; Kao KJ; Pizzo SV; Collins JJ
J Natl Cancer Inst; 1980 Mar; 64(3):547-53. PubMed ID: 6928240
[No Abstract] [Full Text] [Related]
2. Immunotherapy of murine leukemia. VIII. Efficacy of passive serum therapy of Friend leukemia virus-induced disease in immunocompromised mice.
Genovesi EV; Livnat D; Collins JJ
J Natl Cancer Inst; 1983 Feb; 70(2):311-22. PubMed ID: 6337292
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
Sanfilippo F; Genovesi EV; Collins JJ
J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
[TBL] [Abstract][Full Text] [Related]
4. Tumor neutralization, immunotherapy, and chemoimmmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro.
Cheever MA; Kempf RA; Fefer A
J Immunol; 1977 Aug; 119(2):714-8. PubMed ID: 886192
[No Abstract] [Full Text] [Related]
5. Adoptive transfer of antiviral resistance by lymphoid cells from mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Collins JJ; Genovesi EV; Livnat D; Sanfilippo F
Cancer Res; 1981 Jun; 41(6):2407-15. PubMed ID: 7016314
[No Abstract] [Full Text] [Related]
6. Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.
Ward EC; Iglehart JD; Weinhold KJ; Bolognesi DP
J Natl Cancer Inst; 1982 Aug; 69(2):509-15. PubMed ID: 6955550
[TBL] [Abstract][Full Text] [Related]
7. Absence of macrophage involvement in the passive serum therapy of Friend leukemia virus-induced disease.
Collins JJ; Snyderman R
Cancer Res; 1980 Mar; 40(3):557-62. PubMed ID: 6258783
[TBL] [Abstract][Full Text] [Related]
8. Prevention of spontaneous leukemia in AKR mice by passive immunization and type specificity of this protection.
Fish DC; Gilden RV; Bare RM; Trimmer RM; Huebner RJ
J Natl Cancer Inst; 1979 Apr; 62(4):943-5. PubMed ID: 219284
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in Friend virus leukemia. II. Prevention of friend leukemia by passive administration of immune serum and cells to young mice.
Wahren B
J Natl Cancer Inst; 1968 Oct; 41(4):931-8. PubMed ID: 5693664
[No Abstract] [Full Text] [Related]
10. Effects of Friend leukemia virus (FLV) inoculation in F1 mice and differentiation of FLV-induced leukemia.
Kitagawa M; Matsubara O; Kasuga T
Histol Histopathol; 1986 Oct; 1(4):335-40. PubMed ID: 2980128
[TBL] [Abstract][Full Text] [Related]
11. Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia.
Britt WJ; Chesebro B
J Immunol; 1983 May; 130(5):2363-7. PubMed ID: 6833759
[TBL] [Abstract][Full Text] [Related]
12. Serochemotherapy against a Moloney virus-induced leukemia.
Pearson GR; Redmon LW; Pearson JW
Cancer Res; 1973 Aug; 33(8):1854-7. PubMed ID: 4578564
[No Abstract] [Full Text] [Related]
13. Treatment of established tumor by adoptive immunotherapy with specifically immune T cells.
Greenberg PD; Cheever MA
Surv Immunol Res; 1985; 4(4):283-96. PubMed ID: 3879738
[No Abstract] [Full Text] [Related]
14. Protective effect of immunization with polyinosinic-polycytidylic acid complexed with methylated bovine serum albumin against Friend leukemia virus in mice.
Fourcade A; Friend C; Lacour F; Holland JG
Cancer Res; 1974 Jul; 34(7):1749-51. PubMed ID: 4833920
[No Abstract] [Full Text] [Related]
15. The passive immunotherapy of murine leukaemia. I. The production of antisera against leukaemic antigens.
Motta R
Rev Eur Etud Clin Biol; 1970 Feb; 15(2):161-7. PubMed ID: 4315341
[No Abstract] [Full Text] [Related]
16. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of murine leukemia. XI. differential susceptibility of spleen cells from serum-protected mice to the in vitro immunosuppressive effects of Friend leukemia virus-infected splenocytes.
Pettey CL; Collins JJ
Int J Cancer; 1984 Aug; 34(2):269-76. PubMed ID: 6540757
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy in Friend virus leukemia. I. Prevention of Friend leukemia in the offspring of immunized mothers.
Wahren B
J Natl Cancer Inst; 1968 Oct; 41(4):923-9. PubMed ID: 5693663
[No Abstract] [Full Text] [Related]
19. Studies on the role of the host immune response in recovery from Friend virus leukemia. I. Antiviral and antileukemia cell antibodies.
Chesebro B; Wehrly K
J Exp Med; 1976 Jan; 143(1):73-84. PubMed ID: 1244422
[TBL] [Abstract][Full Text] [Related]
20. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
